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Abstract
Introduction: Primitive neuroectodermal tumors (PNETs) occur predominantly in childhood
preferentially in the soft tissues of the lower extremity and the paraspinal region. We present here a
rare case of a PNET of the kidney in an adult.
Case presentation: A tumor adjacent to the right kidney was detected by ultrasound coincidentally
at a routine check-up in a 46-year-old woman with irritable bowel syndrome in her medical history.
The patient had no clinical signs. Contrast-enhanced computerized tomography scan of the abdomen
demonstrated a highly vascularized renal tumor. A retroperitonealectomy with en-bloc resection of
the kidney was performed, and histopathological work-up showed a primitive neuroectodermal
tumor of the kidney with the characteristic translocation t(11;22)(q24;q12).
Conclusion: This tumor entity must be accurately distinguished from other renal neoplasms
because of the prognostic and therapeutic impact.
Introduction
Small round cell tumors of the kidney encompass a broad
range of neoplasms including lymphoma, clear cell
sarcoma of the kidney, neuroblastoma, monophasic
Wilms’ tumor, carcinoid, desmoplastic small round cell
tumor, synovial sarcoma and extraskeletal Ewing sarcoma/
primitive neuroectodermal tumor (ES/PNET) with over-
lapping morphologic features but different therapeutic
regimes. The latter is a rare neoplasm with early regional
and distant (lungs, liver, bone) metastasis [1]. The
prognosis is poor with a 5-year disease-free survival rate
of about 50% despite multimodal therapy [2]. The
diagnosis and differential diagnosis is based on immuno-
histochemical phenotypes and molecular studies [3]. In
1994, Mor described the first case of a ES/PNET in the
kidney [4].
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Case presentation
During medical examination on the occasion of a routine
sonography, an asymptomatic tumor directly near the
right kidney and with possible renal origin was detected in
a 46-year-old Caucasian woman and Swiss citizen with a
history of former smoking with 10 pack-years, irritable
bowel syndrome with recurring mild abdominal pain, and
a past fibroadenoma excision in the right breast five years
ago. The patient complained neither of micturition
symptoms nor of fever or feebleness. She had no history
of weight loss, but she suffered from night sweats for one
month. She had no medication history, and physical
findings and laboratory tests were normal. Contrast-
enhanced CT scan of the abdomen showed a highly
vascularized, well-defined renal tumor with dimensions of
45 × 65 × 102 mm. The mass extended towards the renal
pelvis and the right kidney itself was therefore laterally
displaced. There was an apparent infiltration of the
renal parenchyma or the urinary tract collection system
(Figure 1). The 3D-reconstruction of abdominal CT
angiography at arterial phase showed an extensive tumor
vascularization with feeding and draining vessels and
arteriovenous shunt formation (Figure 2). Abdominal MRI
confirmed thetumor withan extensivevascularization. We
performed anopen retroperitonealectomy with removalof
the right kidney en-bloc with a caudo-cranial-mobilization
of the tumor and several ligations of the ovarian vein, the
duplicated renal artery, and the likewise duplicated renal
vein. The tumor showed extremely dilated veins on its
surface.
Macroscopically, the nephrectomy specimen measured
15 × 12 × 6 cm and weighted 468 g. Almost the whole
kidney was infiltrated by a tan to grey, soft tumor mass
with multiple foci of necrosis. The tumor had spread to the
renal hilus with encasement of the renal artery and vein;
the perirenal fatty tissue was free of tumor. The resection
margins were free of tumor.
Histological examination revealed a uniform population of
tumor cells with round to oval nuclei, very small nucleoli,
smoky chromatin, slightly irregular nuclear membranes
and small, intensely PAS+ cytoplasm (Figure 2c). Numer-
ous signs of mitosis and scattered apoptosis as well
as geographic zones of necrosis were encountered
(Figures 3-5).
Immunohistochemical stainings were performed using the
automated Bond-maX system (Vision Biosystems, Novo-
castra). The tumor cells showed strong positivity for CD99
(1:200, Novocastra) (Figure 6), vimentin (1:1000, Dako)
and NSE (neuron specific enolase, 1:200, Novocastra).
Figure 1. Contrast-enhanced CT scan of the abdomen shows
a well-defined, highly vascularized renal tumor. The mass
extends towards the renal pelvis and the right kidney is
laterally displaced. Tumor borders are indicated by arrows.
Figure 2. CT angiography of the abdomen at arterial phase
shows an extensive tumor vascularization with feeding and
draining vessels and arteriovenous shunt formation: Feeding
renal arteries (white arrows). Main draining vein (black
arrowhead). Pathological vessels (white arrowheads).
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EMA (1:50, Dako), S100 (1:24000, Dako), LCA (1:800,
DAKO)], CD117 (1:50, Dako), and CD34 (1:400, Dako)
were negative.
In molecular studies (performed by L. Guillou, University
of Lausanne, Switzerland), the tumor showed the char-
acteristic translocation t(11;22)(q24;q12) with a EWSR1/
FLI1 fusion transcript. A diagnosis of primary ES/PNET of
the kidney was rendered [4].
Postoperatively, the patient recovered well and was
discharged from the hospital after 14 days. She was treated
according to the EURO/E.W.I.N.G. 99-protocol with
one course of VAI (vincristine, actinomycin D and
ifosfamide), followed by seven chemotherapy courses
according to the FVAC schema (vincristine, actinomycin
and Endoxan).
Discussion
ES/PNETs of the kidney are extremely rare disease
entities [5] and are morphologically and immunophe-
notypically indistinct from extrarenal ES/PNET [6]. They
Figure 3. At scanning magnification (HE stain, ×40), a highly
cellular neoplasm is seen infiltrating the kidney.
Figure 4. At higher magnification (×200), the neoplasm
appears to be composed of tumor cells with round to oval
nuclei, very small nucleoli, smoky chromatin, slightly irregular
nuclear membranes.
Figure 5. At higher magnification (×200), the neoplasm
appears to be composed of tumor cells with round to oval
nuclei, very small nucleoli, smoky chromatin, slightly irregular
nuclear membranes and small, intensely PAS+ cytoplasm.
Figure 6. The tumor cells strongly express CD99 (×200).
Page 3 of 4
(page number not for citation purposes)
Cases Journal 2009, 2:6791 http://casesjournal.com/casesjournal/article/view/6791show the same gene fusions [7] and have a similar poor
outcome. In 1994, Mor described the first case of a renal
ES/PNET [4]. Subsequently, several case reports and
small series of renal PNET were reported in the literature
[6,8-10]. Reportedly, renal ES/PNET usually arises in
young adults and shows a slight male predominance.
Clinically, the tumors usually behave aggressively with
frequent metastasis and tumor-related death. In our
case, the tumor was asymptomatic and only detected
coincidentally. Histologically, several other small round
cell tumors enter into the differential diagnosis of renal
ES/PNET. Morphological, immunophenotypical and
molecular studies are needed to exclude a blastema-
predominant Wilms’ tumor (which may show areas of
stromal or epithelial differentiation, is rarely CD99
positive but frequently shows WT1 expression), meta-
static neuroblastoma and clear cell sarcoma (which
usually arise in younger patients), synovial sarcoma
(which commonly expresses cytokeratin or EMA and
shows the characteristic t(X;18)), and small cell carci-
noma and lymphoma (which show completely different
immunophenotypes). Nonuniform nomenclature of the
entity “renal ES/PNET” may have led to underreporting
of this entity [11].
Conclusion
Renal ES/PNET is rare. Differentiation of small round cell
tumors of the kidney may be challenging, and asympto-
matic lesions in this location are often detected only by
chance. In spite of surgical removal and the application
of chemotherapy in this chemosensitive tumor with the
same nosologic form as Ewing’s sarcoma [12], disease-free
survival is poor.
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